U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07686094) titled 'Placental Cells for Diabetic Foot Ulcers' on June 30.
Brief Summary: The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Diabetic Foot Ulcer
Intervention:
DRUG: Placenta Stem Cells
Injection of 30 M placenta stem cells into/around the diabetic foot ulcer and along the anterior and posterior tibial arteries of the index leg.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Wake Forest University Health Sciences
Disclaimer: Curated by HT Syndication....